PERSPECTA

News from every angle

← Back to headlines

Soleno Therapeutics, Inc. (SLNO) Revenue Tops Expectations With $91.7M in Q4 Results, TD Cowen Maintains Buy

4 Mar, 07:30 — 4 Mar, 07:30
PostShare

Sources

Showing 1 of 1 sources